Business context and reporting period
Banco Santander, S.A. filed this Form 20-F annual report for the fiscal year ended December 31, 2020. It reports consolidated results under IFRS as issued by the IASB; amounts below are in euros unless stated otherwise. Although the request metadata says “2020 Q4,” this filing is an annual report and the supplied text does not provide a clear standalone fourth-quarter income statement.
The Group operates across Europe, North America and South America, serving 148.3 million customers. Its 2020 performance was shaped by the COVID-19 pandemic, lower interest rates, reduced customer activity and currency depreciation.
Key financial metrics
| Metric | 2020 | 2019 | Change / context |
|---|---|---|---|
| Total income (IFRS) | €44.3bn | €49.2bn | Down 10.1%; approximately flat excluding currency effects |
| Net interest income | €32.0bn | €35.3bn | Down 9.3%; up 1.3% excluding currency effects |
| Net fee income | €10.0bn | €11.8bn | Down 15.0%; down 4.5% excluding currency effects |
| Operating expenses | €21.1bn | €23.3bn | Down 9.2%; down 1.2% excluding currency effects |
| Net operating income (IFRS) | €23.1bn | €25.9bn | Down 10.8% |
| Profit/(loss) before tax (IFRS) | (€2.1bn) | €12.5bn | Turned to a loss |
| Attributable profit/(loss) (IFRS) | (€8.8bn) | €6.5bn | Basic EPS was (€0.538), versus €0.347 |
| Underlying attributable profit | €5.1bn | €8.3bn | Down 38.4% in euros; down 29.5% excluding currency effects |
| Underlying net operating income | €23.6bn | €26.2bn | Down 9.8% in euros; up 2.5% excluding currency effects |
| Efficiency ratio | 47.0% | 47.0% | Unchanged |
| Underlying RoTE | 7.44% | 11.79% | Lower year over year |
| Net impairment losses on financial assets | €12.4bn | €9.4bn | Up 32.4% in euros; pandemic-related expected losses and lending growth contributed |
Balance sheet, liquidity and capital
- Total assets were €1,508.3bn, down 0.9%; net loans and advances to customers were €916.2bn, down 2.8% in euros but up 5% excluding currency effects. Customer deposits were €849.3bn, up 3.0%.
- Total liabilities were €1,416.9bn and total equity €91.3bn, down 17.5% from €110.7bn. The equity decline reflected losses and adverse other comprehensive income, including currency translation effects.
- Operating cash flow was €66.2bn, investing cash flow was (€7.2bn), and financing cash flow was (€1.9bn). Cash and cash equivalents increased €52.8bn to €153.8bn. Bank cash flows are affected by changes in financial assets and liabilities and should not be read as industrial-company free cash flow.
- Liquidity remained above regulatory minima: Group LCR was 168% versus 147% in 2019, and NSFR was 120% versus 112%. The net loan-to-deposit ratio improved to 108% from 114%; the structural liquidity surplus was €181.9bn.
- Phased-in CET1 was 12.34%, up 69 basis points, and the fully loaded CET1 ratio was 11.89%. The phased-in total capital ratio was 16.18%. The Group stated a medium-term CET1 target range of 11%–12%.
- Medium- and long-term wholesale debt issued to third parties was €167.4bn, with a 4.7-year weighted average maturity; short-term wholesale funding was €23.2bn. Total customer funds, including mutual and pension funds and managed portfolios, were €1,056.1bn.
Material changes versus the prior comparable period
- Underlying profit fell materially despite broadly stable underlying income in constant euros, reflecting higher credit-loss provisions, weaker fees and regional currency depreciation.
- COVID-19-related overlays and other credit provisions contributed to the increase in impairment charges; the Group’s cost of credit rose to 1.28% from 1.00%.
- Goodwill and deferred tax asset write-downs drove the IFRS net loss. The Group recorded €10.1bn of goodwill impairment and a €2.5bn impairment of deferred tax assets, principally related to Spain.
- Customer deposits grew while lending fell in reported euros; the Group attributed the difference partly to currency translation, government-supported lending and increased precautionary savings.
- The share price fell 29.0% to €2.538, and market capitalization fell 29.0% to €44.0bn. Shares outstanding rose 4.3%, including a December capital increase that issued 722.5 million shares, equivalent to 4.35% of capital.
Outlook, management commentary, risks and unusual items
Management expected economic recovery in 2021 as vaccination advanced and public support continued, while cautioning that renewed outbreaks and restrictions could weigh on early-year activity and that many economies might not regain pre-crisis levels until 2022. The Group emphasized One Santander, PagoNxt and the Digital Consumer Bank as strategic growth and efficiency initiatives. Medium-term regional RoTE and efficiency ambitions were described as goals, not guidance.
Management identified COVID-19, credit deterioration as support measures expire, low-for-longer interest rates, market and foreign-exchange volatility, political and regulatory changes, funding access, cyber risk, competition and climate transition as key risks. Customer payment moratoria reached €112bn for 4.8 million customers; 79% had expired by year-end, and 3% of expired balances were classified in Stage 3. Total provisions for contingent liabilities were €4.4bn. Disclosed matters include litigation and regulatory proceedings; the filing says outcomes and possible additional losses may remain uncertain.
Shareholder distributions were constrained by ECB recommendations. The board announced an intended 2020 cash dividend of €0.0275 per share, the maximum permitted under the December 2020 recommendation, and aims to restore a 40%–50% cash payout of underlying profit over the medium term. The 2019 remuneration included a €0.10-per-share scrip distribution. PwC issued an unqualified audit opinion and concluded internal control over financial reporting was effective. The audit identified critical audit matters involving loan impairment estimates, goodwill impairment, deferred tax asset recoverability and contingent-liability provisions.
Most important facts for investors to verify
- Reconcile the €8.8bn IFRS loss to the €5.1bn underlying profit, including the €10.1bn goodwill impairment, €2.5bn deferred tax asset write-down and €1.1bn restructuring costs.
- Review credit-loss assumptions, the €3.1bn COVID-19 overlay, moratoria outcomes and the sensitivity of provisions to economic scenarios as support programmes expire.
- Confirm capital and dividend capacity against regulatory requirements, including the 11%–12% CET1 target, the fully loaded ratio and the ECB’s distribution limits.
- Assess liquidity and funding trends, including the high LCR and NSFR, deposit growth, central-bank funding and wholesale-debt maturities.
- Review material litigation and tax exposures, including Banco Popular-related claims, UK PPI matters and Polish CHF mortgage litigation; verify whether recorded provisions remain adequate.
- Compare annual results with any separately reported fourth-quarter figures; this filing text does not provide clear standalone Q4 financial values.